Abstract:Objective To evaluate the feasibility of interferon γ gene transferred glioblastoma. Methods Mouse IFN γ gene was introduced into mouse glioblastoma cell line G422 by recombinant adenovirus vector (G422/mIFN γ). IFN γ secretion by G422/mIFN γ was assayed by ELISA and proliferation potential of G422/mIFN γ in vitro was weasured by MTT assay. the tumor size and survival of tumor bearing mice were observed after G422/mIFN γ(experiment group), LacZ gene transfected G422(viral control group) and wild type G422(cell control group) were inoculated subcutaneously receptively. The levels of serum IFN γ, IL 2,TNFα,NO and the secretion of TNFα and NO by celiac M after Lps stimulation were measured, the splenic NK, CTL and celiac M cytotoxicity were also analyzed by non radioactive quantitative lactate dehydrogenase release assay.Results High level of mouse IFN γ could be detected in the culture supernatant of G422/mIFN γ(8000pg/ml) and mouse serum of experiment group (805 0±116 2pg/ml), there was no significantly change of the proliferation potential in vitro among the 3 groups (P0 05). after vaccine inoculated subcutaneously, the tumor growth of experiment group was significantly inhibited compating with two control groups, the survival of mice was also significantly prolongated with 4/6 long term survival mice (P0 01), when stmulated with LPS, the celiac M secreted much more TNFα and NO (565 8±264 6pg/ml and 158 3±21 6μ mol/L respectively), the splenic NK,CTL and celiac M cytotoxicity were also significantly enhanced (53 7±7 4%?65 4±7 4%和47 5±5 9 respectively)(P0 05).Conclusions The IFN γ gene transferred G422 glioblastoma could induce the specific anti tumor immunity in vivo.

Induction of specific anti-tumor immunity by interferon-γ gene transferred G422 mouse glioblastoma